# Latigo Biotherapeutics, Inc.: insider transactions

LTGO · Nasdaq · CIK 2056611 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ltgo.md) · [Financials](/companies/ltgo/financials.md) · [Filings](/companies/ltgo/filings.md) · [Insiders](/companies/ltgo/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-08-10 | [Sanofi](/insiders/1121404.md) | 10% owner | Conversion (C) | 177,978 | not reported | not reported | [Form 4](/filings/0001193125-26-345826.md) |
| 2026-08-10 | [Sanofi](/insiders/1121404.md) | 10% owner | Conversion (C) | 494,800 | not reported | not reported | [Form 4](/filings/0001193125-26-345826.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 18:05 ET. No prices; not investment advice.